These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 2867389)
41. Ovulation induction using s.c. pulsatile gonadotrophin-releasing hormone: effectiveness of different pulse frequencies. Letterie GS; Coddington CC; Collins RL; Merriam GR Hum Reprod; 1996 Jan; 11(1):19-22. PubMed ID: 8671151 [TBL] [Abstract][Full Text] [Related]
42. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505 [TBL] [Abstract][Full Text] [Related]
43. Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease. Steingold K; De Ziegler D; Cedars M; Meldrum DR; Lu JK; Judd HL; Chang RJ J Clin Endocrinol Metab; 1987 Oct; 65(4):773-8. PubMed ID: 3116031 [TBL] [Abstract][Full Text] [Related]
44. Comparison between pulsatile GnRH therapy and gonadotropins for ovulation induction in women with both functional hypothalamic amenorrhea and polycystic ovarian morphology. Dumont A; Dewailly D; Plouvier P; Catteau-Jonard S; Robin G Gynecol Endocrinol; 2016 Dec; 32(12):999-1004. PubMed ID: 27258574 [TBL] [Abstract][Full Text] [Related]
45. The distribution of oestradiol in plasma in relation to uterine cross-sectional area in women with polycystic or multifollicular ovaries. Polson DW; Franks S; Reed MJ; Cheng RW; Adams J; James VH Clin Endocrinol (Oxf); 1987 May; 26(5):581-8. PubMed ID: 3665120 [TBL] [Abstract][Full Text] [Related]
46. Treatment with pulsatile luteinizing hormone-releasing hormone modulates folliculogenesis in response to ovarian stimulation with exogenous gonadotropins in patients with polycystic ovaries. Homburg R; Kilborn J; West C; Jacobs HS Fertil Steril; 1990 Oct; 54(4):737-9. PubMed ID: 2120089 [TBL] [Abstract][Full Text] [Related]
47. An intractable, ovary-independent impairment in hypothalamo-pituitary function in the estradiol-valerate-induced polycystic ovarian condition in the rat. Simard M; Brawer JR; Farookhi R Biol Reprod; 1987 Jun; 36(5):1229-37. PubMed ID: 3113503 [TBL] [Abstract][Full Text] [Related]
48. Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH. Tan SL; Farhi J; Homburg R; Jacobs HS Obstet Gynecol; 1996 Aug; 88(2):221-6. PubMed ID: 8692506 [TBL] [Abstract][Full Text] [Related]
50. A practical guide to the diagnosis and management of amenorrhoea. Crosignani PG; Vegetti W Drugs; 1996 Nov; 52(5):671-81. PubMed ID: 9118817 [TBL] [Abstract][Full Text] [Related]
51. Intravenous administration of pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea: effects of dosage. Santoro N; Wierman ME; Filicori M; Waldstreicher J; Crowley WF J Clin Endocrinol Metab; 1986 Jan; 62(1):109-16. PubMed ID: 3079597 [TBL] [Abstract][Full Text] [Related]
52. Ovulation induction with pulsatile gonadotropin-releasing hormone administration in patients with polycystic ovarian syndrome. Ory SJ; London SN; Tyrey L; Hammond CB Fertil Steril; 1985 Jan; 43(1):20-5. PubMed ID: 3880710 [TBL] [Abstract][Full Text] [Related]
53. Ovulation induction and pregnancy in women with hypothalamic amenorrhea treated with intermittent gonadotropin-releasing hormone. Corenblum B; Mackin J; Taylor PJ J Reprod Med; 1985 Oct; 30(10):736-40. PubMed ID: 3934370 [TBL] [Abstract][Full Text] [Related]
54. Pregnancy after prolonged pulsatile administration of luteinizing hormone-releasing hormone in a patient with clomiphene-resistant secondary amenorrhea. Schoemaker J; Simons AH; van Osnabrugge GJ; Lugtenburg C; van Kessel H J Clin Endocrinol Metab; 1981 May; 52(5):882-5. PubMed ID: 6785291 [TBL] [Abstract][Full Text] [Related]
55. Value of subcutaneous and intravenous pulsatile gonadotropin releasing hormone in polycystic ovary disease. Saffan DS; Seibel MM J Reprod Med; 1992 Jun; 37(6):545-51. PubMed ID: 1619610 [TBL] [Abstract][Full Text] [Related]
56. Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome. Bayram N; van Wely M; Vandekerckhove P; Lilford R; van Der Veen F Cochrane Database Syst Rev; 2000; (2):CD000412. PubMed ID: 10796718 [TBL] [Abstract][Full Text] [Related]
58. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease. de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501 [TBL] [Abstract][Full Text] [Related]
59. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea. Couzinet B; Young J; Brailly S; Chanson P; Schaison G J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262 [TBL] [Abstract][Full Text] [Related]
60. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. Adams JM; Taylor AE; Crowley WF; Hall JE J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]